«From this data, it's clear that we have to make strides in
supporting allogeneic BMT recipients in their recovery to ensure that we are educating patients and their families on signs of cognitive impairment.
Not exact matches
There is
supporting evidence for the use of
allogeneic MSC from both in vitro and in vivo studies that show MSC avoid normal allo - responses.
These reports suggest that transplantation of MSC could be beneficial in patients with various disorders requiring tissue regeneration, and provide evidence
supporting the tolerance of
allogeneic MSC by recipients.
This finding
supports the hypothesis that parous women with breast cancer fail to harbor a potential source of naturally acquired
allogeneic immunity.